{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:25:21Z","timestamp":1787505921974,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>COVID-19 is associated with neurological complications, termed neuro-COVID, affecting patient outcomes. We aimed to evaluate the association between serum neurofilament light chain (NfL) and S100B biomarkers with the presence of neurological manifestations and functional prognosis in COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicenter prospective cohort study was conducted in three hospitals in the Emilia-Romagna region, Italy, from March 2020 to April 2022. Hospitalized patients with PCR-confirmed COVID-19 were enrolled. Serum S100B and NfL levels were measured in the acute or subacute phase after admission. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) analyses. Statistical analyses were performed to evaluate the association between biomarkers, clinical\/laboratory variables, and prognosis, specifically focusing on worsening of the modified Rankin Scale (mRS) from admission to discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 279 patients (153 males, median age 76.7\u00a0years) were included. Among them, 69 (24.7%) developed neuro-COVID. Serum NfL levels were significantly higher in the neuro-COVID group (median 110 vs 68.3;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.035) and correlated with severe encephalopathy and extracranial neurologic manifestations. The ROC analysis showed low accuracy in the discrimination between the two groups for both NfL and S100B. Key predictors of worsening mRS included mechanical ventilation (OR\u2009=\u20099.56, 95% CI\u2009=\u20091.67\u201354.75;\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.011), severe encephalopathy (OR\u2009=\u20095.10, 95% CI\u2009=\u20091.58\u201316.19;\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.006), and elevated S100B levels (OR\u2009=\u20092.62, 95% CI\u2009=\u20091.10\u20136.46;\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.037).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum NfL and S100B biomarkers were not accurate in discriminating neuro-COVID patients, however NfL levels were associated with severe and extracranial neuro-COVID, while S100B with functional outcomes, potentially informing clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-024-07964-0","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T16:18:21Z","timestamp":1736353101000},"page":"527-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study"],"prefix":"10.1007","volume":"46","author":[{"given":"Francesca","family":"Bisulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-0099","authenticated-orcid":false,"given":"Lorenzo","family":"Muccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Taruffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Felici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Zenesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Baccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Nicodemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"d\u2019Achille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Zaccaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cortelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Janigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Meletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"10229","key":"7964_CR1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet Lond Engl 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet Lond Engl"},{"issue":"9","key":"7964_CR2","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.ajem.2020.05.073","volume":"38","author":"BM Henry","year":"2020","unstructured":"Henry BM, Aggarwal G, Wong J et al (2020) Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med 38(9):1722\u20131726. https:\/\/doi.org\/10.1016\/j.ajem.2020.05.073","journal-title":"Am J Emerg Med"},{"key":"7964_CR3","doi-asserted-by":"publisher","first-page":"m1328","DOI":"10.1136\/bmj.m1328","volume":"369","author":"L Wynants","year":"2020","unstructured":"Wynants L, Van Calster B, Collins GS et al (2020) Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 369:m1328. https:\/\/doi.org\/10.1136\/bmj.m1328","journal-title":"BMJ"},{"issue":"2","key":"7964_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/ene.15617","volume":"30","author":"E Beghi","year":"2023","unstructured":"Beghi E, Moro E, Davidescu EI et al (2023) Comparative features and outcomes of major neurological complications of COVID-19. Eur J Neurol 30(2):413\u2013433. https:\/\/doi.org\/10.1111\/ene.15617","journal-title":"Eur J Neurol"},{"key":"7964_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2147\/NDT.S387501","volume":"19","author":"L Taruffi","year":"2023","unstructured":"Taruffi L, Muccioli L, Mitolo M et al (2023) Neurological Manifestations of Long COVID: A Single-Center One-Year Experience. Neuropsychiatr Dis Treat 19:311\u2013319. https:\/\/doi.org\/10.2147\/NDT.S387501","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"7964_CR6","doi-asserted-by":"publisher","first-page":"e892","DOI":"10.1212\/WNL.0000000000207534","volume":"101","author":"S Beretta","year":"2023","unstructured":"Beretta S, Cristillo V, Camera G et al (2023) Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants. Neurology 101(9):e892\u2013e903. https:\/\/doi.org\/10.1212\/WNL.0000000000207534","journal-title":"Neurology"},{"issue":"4","key":"7964_CR7","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/brain\/awac332","volume":"146","author":"SM Cho","year":"2023","unstructured":"Cho SM, White N, Premraj L et al (2023) Neurological manifestations of COVID-19 in adults and children. Brain J Neurol 146(4):1648\u20131661. https:\/\/doi.org\/10.1093\/brain\/awac332","journal-title":"Brain J Neurol"},{"issue":"7","key":"7964_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1080\/00207454.2021.1973000","volume":"133","author":"ZH Ousseiran","year":"2023","unstructured":"Ousseiran ZH, Fares Y, Chamoun WT (2023) Neurological manifestations of COVID-19: a systematic review and detailed comprehension. Int J Neurosci 133(7):754\u2013769. https:\/\/doi.org\/10.1080\/00207454.2021.1973000","journal-title":"Int J Neurosci"},{"issue":"6","key":"7964_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/ana.26076","volume":"89","author":"E Beghi","year":"2021","unstructured":"Beghi E, Michael BD, Solomon T, Westenberg E, Winkler AS (2021) COVID-19 Neuro Research Coalition. Approaches to understanding COVID-19 and its neurological associations. Ann Neurol 89(6):1059\u20131067. https:\/\/doi.org\/10.1002\/ana.26076","journal-title":"Ann Neurol"},{"issue":"4","key":"7964_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ana.25855","volume":"88","author":"L Muccioli","year":"2020","unstructured":"Muccioli L, Pensato U, Cani I, Guarino M, Cortelli P, Bisulli F (2020) COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation. Ann Neurol 88(4):860\u2013861. https:\/\/doi.org\/10.1002\/ana.25855","journal-title":"Ann Neurol"},{"issue":"4","key":"7964_CR11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/acn3.51348","volume":"8","author":"U Pensato","year":"2021","unstructured":"Pensato U, Muccioli L, Cani I et al (2021) Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann Clin Transl Neurol 8(4):968\u2013979. https:\/\/doi.org\/10.1002\/acn3.51348","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"7964_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/ene.14491","volume":"28","author":"P Perrin","year":"2021","unstructured":"Perrin P, Collongues N, Baloglu S et al (2021) Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol 28(1):248\u2013258. https:\/\/doi.org\/10.1111\/ene.14491","journal-title":"Eur J Neurol"},{"issue":"1","key":"7964_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12987-020-00216-1","volume":"17","author":"MA MacLean","year":"2020","unstructured":"MacLean MA, Kamintsky L, Leck ED, Friedman A (2020) The potential role of microvascular pathology in the neurological manifestations of coronavirus infection. Fluids Barriers CNS 17(1):55. https:\/\/doi.org\/10.1186\/s12987-020-00216-1","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"7964_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s12035-020-02134-7","volume":"58","author":"I Alquisiras-Burgos","year":"2021","unstructured":"Alquisiras-Burgos I, Peralta-Arrieta I, Alonso-Palomares LA, Zacapala-G\u00f3mez AE, Salmer\u00f3n-B\u00e1rcenas EG, Aguilera P (2021) Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection. Mol Neurobiol 58(2):520\u2013535. https:\/\/doi.org\/10.1007\/s12035-020-02134-7","journal-title":"Mol Neurobiol"},{"key":"7964_CR15","doi-asserted-by":"publisher","first-page":"105131","DOI":"10.1016\/j.nbd.2020.105131","volume":"146","author":"TP Buzhdygan","year":"2020","unstructured":"Buzhdygan TP, DeOre BJ, Baldwin-Leclair A et al (2020) The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 146:105131. https:\/\/doi.org\/10.1016\/j.nbd.2020.105131","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"7964_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cccn.2003.12.008","volume":"342","author":"N Marchi","year":"2004","unstructured":"Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, Janigro D (2004) Peripheral markers of blood-brain barrier damage. Clin Chim Acta Int J Clin Chem 342(1\u20132):1\u201312. https:\/\/doi.org\/10.1016\/j.cccn.2003.12.008","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"3\u20134","key":"7964_CR17","first-page":"109","volume":"21","author":"N Marchi","year":"2003","unstructured":"Marchi N, Rasmussen P, Kapural M et al (2003) Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 21(3\u20134):109\u2013121","journal-title":"Restor Neurol Neurosci"},{"issue":"1","key":"7964_CR18","doi-asserted-by":"publisher","first-page":"18665","DOI":"10.1038\/s41598-020-75618-0","volume":"10","author":"A Aceti","year":"2020","unstructured":"Aceti A, Margarucci LM, Scaramucci E et al (2020) Serum S100B protein as a marker of severity in Covid-19 patients. Sci Rep 10(1):18665. https:\/\/doi.org\/10.1038\/s41598-020-75618-0","journal-title":"Sci Rep"},{"key":"7964_CR19","doi-asserted-by":"publisher","first-page":"120324","DOI":"10.1016\/j.jns.2022.120324","volume":"439","author":"BE Sahin","year":"2022","unstructured":"Sahin BE, Celikbilek A, Kocak Y, Saltoglu GT, Konar NM, Hizmali L (2022) Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. J Neurol Sci 439:120324. https:\/\/doi.org\/10.1016\/j.jns.2022.120324","journal-title":"J Neurol Sci"},{"issue":"5","key":"7964_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.26502\/fccm.92920221","volume":"5","author":"M Hay","year":"2021","unstructured":"Hay M, Ryan L, Huentelman M et al (2021) Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness. Cardiol Cardiovasc Med 5(5):551\u2013565. https:\/\/doi.org\/10.26502\/fccm.92920221","journal-title":"Cardiol Cardiovasc Med"},{"issue":"11","key":"7964_CR21","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1093\/brain\/awac321","volume":"145","author":"EJ Needham","year":"2022","unstructured":"Needham EJ, Ren AL, Digby RJ et al (2022) Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain J Neurol 145(11):4097\u20134107. https:\/\/doi.org\/10.1093\/brain\/awac321","journal-title":"Brain J Neurol"},{"issue":"16","key":"7964_CR22","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.3390\/cells11162480","volume":"11","author":"MA Zingaropoli","year":"2022","unstructured":"Zingaropoli MA, Iannetta M, Piermatteo L et al (2022) Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 Patients. Cells 11(16):2480. https:\/\/doi.org\/10.3390\/cells11162480","journal-title":"Cells"},{"issue":"7","key":"7964_CR23","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00415-023-11768-1","volume":"270","author":"A Abdelhak","year":"2023","unstructured":"Abdelhak A, Barba L, Romoli M et al (2023) Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis. J Neurol 270(7):3315\u20133328. https:\/\/doi.org\/10.1007\/s00415-023-11768-1","journal-title":"J Neurol"},{"key":"7964_CR24","doi-asserted-by":"publisher","first-page":"866153","DOI":"10.3389\/fimmu.2022.866153","volume":"13","author":"M Guasp","year":"2022","unstructured":"Guasp M, Mu\u00f1oz-S\u00e1nchez G, Mart\u00ednez-Hern\u00e1ndez E et al (2022) CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome. Front Immunol 13:866153. https:\/\/doi.org\/10.3389\/fimmu.2022.866153","journal-title":"Front Immunol"},{"key":"7964_CR25","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351:h5527. https:\/\/doi.org\/10.1136\/bmj.h5527","journal-title":"BMJ"},{"issue":"9596","key":"7964_CR26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet Lond Engl 370(9596):1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet Lond Engl"},{"key":"7964_CR27","unstructured":"Hospitalized Adults: Therapeutic Management. COVID-19 Treatment Guidelines. Accessed April 26, 2023. https:\/\/www.covid19treatmentguidelines.nih.gov\/tables\/therapeutic-management-of-hospitalized-adults\/"},{"issue":"1","key":"7964_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12879-021-06185-6","volume":"21","author":"JI Guerrero","year":"2021","unstructured":"Guerrero JI, Barrag\u00e1n LA, Mart\u00ednez JD et al (2021) Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis 21(1):515. https:\/\/doi.org\/10.1186\/s12879-021-06185-6","journal-title":"BMC Infect Dis"},{"key":"7964_CR29","doi-asserted-by":"publisher","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/S0140-6736(20)30566-3"},{"issue":"7","key":"7964_CR30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci 11(7):995\u2013998. https:\/\/doi.org\/10.1021\/acschemneuro.0c00122","journal-title":"ACS Chem Neurosci"},{"key":"7964_CR31","doi-asserted-by":"publisher","first-page":"1070379","DOI":"10.3389\/fimmu.2022.1070379","volume":"13","author":"V Bonetto","year":"2022","unstructured":"Bonetto V, Pasetto L, Lisi I et al (2022) Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol 13:1070379. https:\/\/doi.org\/10.3389\/fimmu.2022.1070379","journal-title":"Front Immunol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07964-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07964-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07964-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:14:56Z","timestamp":1737951296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07964-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7964"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07964-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local ethics committee \u201cComitato Etico Area Vasta Emilia Centro\u201d (CE-AVEC): Approval 925\u20132021-OSS-AUSLBO-21182.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written consent was gained from either patients themselves, or from their legal representatives where they lacked the capacity to consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None of the authors have any relevant conflicts of interest to disclose in relation to the present work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}